CDK2 and breast neoplasm: CDK2 is upregulated in breast tumors, and its vital role in cell cycle regulation makes CDK2 an attractive therapeutic target (Sofi et al., 2022a; Mehraj et al., 2022e; Mehraj et al., 2022f).